ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Recursos principais

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
iShares Core Dividend Growth

iShares Core Dividend Growth (DGRO)

64,22
-0,06
(-0,09%)
No fechamento: 05 Dezembro 6:00PM
64,22
0,00
( 0,00% )
Após o horário de negociação: 7:06PM

Calls

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
54,008,0011,900,009,950,000,00 %00-
55,007,3010,505,458,900,000,00 %017-
56,006,3010,407,068,350,000,00 %01-
57,005,008,407,656,700,000,00 %03-
58,004,507,303,005,900,000,00 %03-
59,003,007,202,085,100,000,00 %05-
60,002,006,203,884,100,000,00 %020-
61,001,954,504,003,2250,000,00 %027-
62,001,803,402,952,600,000,00 %019-
63,000,052,452,491,250,000,00 %0160-
64,000,201,050,710,6250,000,00 %0120-
65,000,050,300,250,175-0,19-43,18 %214305/12/2024
66,000,050,350,050,200,000,00 %018-
67,000,020,200,070,110,05250,00 %615.02405/12/2024

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Puts

StrikeOfertaVendaÚltimo PreçoPonto MédioVariação do DiaVariação do Dia %VolumeINT ABERTOÚltimo Negócio
54,000,342,150,341,2450,000,00 %01-
55,000,841,400,841,120,000,00 %09-
56,000,010,250,010,130,000,00 %01.371-
57,000,232,150,231,190,000,00 %09-
58,000,202,150,201,1750,000,00 %044-
59,000,052,550,051,300,000,00 %01-
60,000,051,500,080,7750,000,00 %0195-
61,000,351,450,350,900,000,00 %018-
62,000,750,650,750,700,000,00 %016-
63,000,051,500,740,7750,000,00 %036-
64,000,202,101,191,150,000,00 %04-
65,000,403,300,701,850,000,00 %01-
66,000,754,203,202,4750,000,00 %01-
67,001,704,500,003,100,000,00 %00-

Rankings

Ver todos
  • Volume
  • % Altas
  • % Quedas
CódigoPreçoVol.
ZBAOZhibao Technology Inc
US$ 6,44
(152,55%)
2,21M
PGHLPrimega Group Holdings Ltd
US$ 1,82
(36,33%)
4,24M
GXAIGaxos ai Inc
US$ 1,84
(29,58%)
1,36M
CDIOCardio Diagnostics Holdings Inc
US$ 0,58
(24,89%)
10,32M
HLVXHilleVax Inc
US$ 2,15
(14,97%)
75,1k
ORISOriental Rise Holdings Ltd
US$ 11,10
(-80,18%)
3,58M
ENGENGlobal Corp
US$ 0,6409
(-40,66%)
77,07k
CAMPCAMP4 Therapeutics Corporation
US$ 7,65
(-22,02%)
68,07k
VVPRVivoPower International PLC
US$ 1,06
(-20,90%)
278,2k
BOCNUBlue Ocean Acquisition Corporation
US$ 9,23
(-18,03%)
100
SVMHSRIVARU Holding Ltd
US$ 0,038
(8,57%)
12,05M
CDIOCardio Diagnostics Holdings Inc
US$ 0,58
(24,89%)
10,32M
SMCISuper Micro Computer Inc
US$ 41,27
(0,32%)
7,07M
XTIAXTI Aerospace Inc
US$ 0,0442
(-2,86%)
5,7M
SOUNSoundHound AI Inc
US$ 14,12
(5,93%)
4,54M
LCJR LCJR 2 minutos atrás
Most don't even know what XRP is, much less know the value. No rug pull here, everyone just needs patience and let it play out.

LCJR

XRPUSD
Info3 Info3 3 minutos atrás
In general 
BMXI
misterfishman misterfishman 3 minutos atrás
Nice day today.
RDAR
MartinLutherKing MartinLutherKing 3 minutos atrás
8. TransCode Therapeutics Announces Safety Review Committee Approval of Second Cohort Opening in Phase 1 TTX-MC138 Clinical Trial Following Favorable Review of Cohort 1 Safety Data
October 23 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company co
RNAZ
sluggercjb sluggercjb 3 minutos atrás
lol Orca has the Doc. And all shareholders running scared all those threats are keeping everyone up at night. Orca Please stop being a bully lol ..still get a good laugh at his post
VDRM
LCP77 LCP77 3 minutos atrás
I meet twice a year with my tax advisor (CPA). Once about now, for year end positioning, and then for tax season. I’ve found that to be worthwhile.
NB
bananarama bananarama 5 minutos atrás
Forget about a five dollar BO. After yesterday's Web Conference, that price has already jumped to at least ten dollars. If some white knight waits to buy KBLB, they will be paying twice that amount. GO KBLB!
KBLB
nt2innovate nt2innovate 5 minutos atrás
Yes. Good call. Hopefully buying will increase on the OTC with retail and family offices if they start seeing 30-40% annual growth rates going forward without dilution as you said which will cause the stock price to go up significantly.

The idea of the PEC along with Enclave having va
SDCH
northam43 northam43 5 minutos atrás
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
jsc52033 jsc52033 5 minutos atrás
actualy its down 3,397 from yesterday yet yes way ahead of Tueday which was almost none at 150,000 +
BMXI
MartinLutherKing MartinLutherKing 6 minutos atrás
6.TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
September 17 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer usin
RNAZ
fwb fwb 6 minutos atrás
If it's McDonald NEWS, we could go higher than $20.00
SOUN
XenaLives XenaLives 7 minutos atrás
Define "e" as massive AI manipulation of the market as a whole....
AVXL
band aid band aid 7 minutos atrás
Does anyone think they will figure out how to sell a few more trinkets then they have in the past. I guess we shall see in the once a year financial reports. Then maybe the company may have a couple of bucks in the bank.
BIEL
northam43 northam43 7 minutos atrás
Report # 6.1 SPX Cycles Short Range Chart (60 min & Daily Cycles)

https://investorshub.advfn.com/uimage/uploads/2024/12/5/stiec6.1_Short_Term.png
zab zab 7 minutos atrás
The trump clown show is in full display for everyone to see, another reason only 49 percent of America voted for orange shittypants.  But remember trump will blame everyone else for his daily mistakes,  and meltdowns.
MartinLutherKing MartinLutherKing 7 minutos atrás
5.TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10 2024 - 7:00AM


TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology compan
RNAZ
misterfishman misterfishman 7 minutos atrás
There is plenty of frustration going on over here mostly due to impatience peeps this stock is a longterm play like a few years out if peeps can't wait then sell.its that simple.
IGPK
bananarama bananarama 8 minutos atrás
I totally agree with you, Monkey! Any company interested in buying KBLB would recognize that it is better to buy the company now rather than wait for it to reach the Texas Exchange (or the NASDQ). Then, the BO price will be MUCH MUCH higher. GO KBLB! ;-)
KBLB
MartinLutherKing MartinLutherKing 8 minutos atrás
4.TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05 2024 - 7:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today an
RNAZ

Seu Histórico Recente